Mechanical support of the unrepaired postinfarction ventricular septal defect with the abiomed BVS 5000 ventricular assist device  by Samuels, Louis E et al.
tions are more often associated with a left-sided cervical arch.
Physical examination reveals a large pulsatile mass in the supra-
clavicular region.4 3D-CT, angiography and MRA are useful for
definite diagnosis and surgical treatment.
Deletion of chromosome 22q11 was recently reported in some
cases of cervical aortic arch5 but was not evident in this case. The
female predilection for aneurysm formation is consistent with a
genetic factor.1
The pathologic finding of cystic medial degeneration in the
aneurysm has been reported in a large surgical series and supports
the importance of recognition and surgical intervention in this
condition, whether patients are symptomatic or not.2
References
1. Farsak B, Yilmaz M, Kaplan S, Bo¨ke E. Cervical aortic arch with
aneurysm formation. Eur J Cardiothorac Surg. 1998;14:437-9.
2. Cooly DA, Mullins CE, Gooch JB. Aneurysm of right-sided cervical
arch; surgical removal and graft replacement. J Thorac Cardiovasc
Surg. 1976;72:106-8.
3. Reid DG. Three examples of a right aortic arch. J Anat Physiol.
1914;48:174-81.
4. Morris R, Ruttley M. Left cervical aortic arch associated with aortic
aneurysm. Br Heart J. 1978;40:87-90.
5. Kumar A, McCombs JL, Sapire DW. Deletions in chromosome
22q11 region in cervical aortic arch. Am J Cardiol. 1997;79:388-
90.
Mechanical support of the unrepaired postinfarction ventricular septal
defect with the Abiomed BVS 5000 ventricular assist device
Louis E. Samuels, MD, John C. Entwistle III, MD, Elena C. Holmes, CRNP, Ted Parris, MD, and Andrew S. Wechsler, MD,
Philadelphia, Pa
The Abiomed BVS 5000 (Abiomed, Inc, Danvers, Mass)is an extracorporeal pneumatic ventricular assist device(VAD) that has been used in a variety of acute cardiacconditions.1 The purpose of this report is to describe the
use and cannulation strategy of the BVS 5000 VAD as a bridge to
transplantation in a case of unrepaired postinfarction ventricular
septal defect (VSD).
Clinical Summary
A 62-year-old American man with a history of coronary artery
disease had a myocardial infarction while in the Dominican Re-
public on September 6, 2001. On September 11, 2001, he became
hypotensive from reinfarction. Physical examination revealed a
new heart murmur. An echocardiogram showed a posterior ven-
tricular VSD. He was given intravenous dopamine and prepared
for transfer to the United States for further management. As a
result of the World Trade Center attack, air transportation was
suspended. On September 13, 2001, permission was granted for an
emergency flight to Philadelphia. The patient was in cardiogenic
shock with multiple organ system failure. He was intubated, he
was given additional inotropic and vasoconstrictive drugs, and an
intra-aortic balloon pump was inserted. The catheterization
showed severe-triple vessel coronary artery disease (poor runoff)
with moderate pulmonary hypertension and a large posterior VSD.
The right atrial, right ventricular, and pulmonary artery saturations
demonstrated a shunt at the ventricular level (Table 1). The patient
was transferred to the operating room for management.
The patient was placed on cardiopulmonary bypass with mild
hypothermia. The heart showed minimal contractility and a mas-
sive acute posterior wall myocardial infarction. The decision was
made to place the Abiomed VAD without repairing the VSD or
bypassing the coronary arteries. Inflows to the blood pumps were
established at the atrial level and outflows were to the great
arteries. The patient was weaned from cardiopulmonary bypass
with excellent hemodynamic and mechanical support (5 L/min).
The patient was transported to the cardiothoracic intensive care
unit in stable condition, with elimination of the shunt (Table 1).
After the operation, the patient awoke with an intact neurologic
status and stable vital signs. He remained on VAD support for 8
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TABLE 1. Oxygen saturations and hemodynamic variables
before and after VAD placement
Before VAD After VAD
Oxygen saturation
Right atrium 60% 58%
Right ventricle 93% 62%
Pulmonary artery 82% 63%
Aorta 95% 100%
Systemic blood pressure (mm Hg) 80/50 152/86
Pulmonary arterial pressure (mm Hg) 55/33 24/14
Central venous pressure (mm Hg) 28 12
Cardiac output (L/min) 3.4 5.3
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weeks, with improvement in hepatic function. Although the renal
function improved, the creatinine clearance was poor. The patient
underwent intermittent dialysis through side access ports on the right
VAD tubing. Assessment of cardiac recovery was performed with
serial echocardiograms, demonstrating persistent severe biventricular
failure. The decision was made to list the patient for heart and kidney
transplantation. On November 12, 2001, the patient underwent suc-
cessful double organ transplantation. The postoperative course was
uneventful, with no major complications. The patient was discharged
to a rehabilitation center for several months of recovery. He was then
discharged to home and remains alive and well more than 1 year later.
Discussion
The management of postinfarction VSD remains a therapeutic
challenge. Surgical mortality remains high, and initial repairs may
be plagued by persistent heart failure, VSD recurrence, and ar-
rhythmia.2 As such, this entity continues to be the subject of
cardiothoracic surgical debate regarding the timing and type of
surgical repair.
One novel approach to this entity includes the use of a ven-
tricular assist device (VAD) for cardiac support, circulatory sta-
bility, and maintenance of end-organ perfusion. The role of the
VAD may be as an adjunct to an attempted repair. In this scenario,
the postinfarct VSD is repaired, coronary bypass grafting is per-
formed, and the VAD is placed for ventricular unloading and
maintenance of adequate cardiac output. The use of implantable
VADs for this condition was described by Faber and colleagues3
with the HeartMate (Thoratec Laboratories, Pleasanton, Calif) and
Novacor (WorldHeart Corp, Ottawa, Ontario, Canada) systems.
Another scenario, however, is to place the VAD without attempt-
ing an initial repair. The rationale behind this approach is to avoid
operating on fresh infarct and to establish prompt circulatory
control. The BVS 5000 VAD has the advantage that it can be
placed with or without cardiopulmonary bypass. In addition, in-
flow to the VAD can be easily accomplished at the atrial level.
This is an ideal cannulation strategy for a VSD, in which it is
important to avoid a shunt at the ventricular level. As demonstrated
in our case, mechanical cardiac support was successful in restoring
hemodynamic stability and reversal of multiorgan system failure.
In conclusion, the postinfarction VSD may be managed in a
variety of ways. This case demonstrates the novel use of the BVS
5000 VAD with biatrial cannulation for the uncorrected postin-
farction VSD as a bridge to transplantation.
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Urgent inferior vena cava replacement with an autologous pericardium
tube graft
B-Khanh Lam, MD,a Gosta B. Pettersson, MD,a and David P. Vogt, MD,b Cleveland, Ohio
Surgical interventions involving the suprarenal inferiorvena cava (IVC) are uncommon. They are usually re-quired after the partial or complete resection of the IVCfor the management of malignant and nonmalignant dis-
eases.1,2 Three surgical techniques have been reported: patch angio-
plasty,3 replacement with spiral saphenous vein graft,1 and replace-
ment with extended polytetrafluoroethylene (ePTFE) grafts.1,2,4 We
report on an emergency case in which the accidentally transected
suprarenal IVC was replaced with an autologous pericardial tube.
Clinical Summary
A 42-year-old male man had right-sided flank pain and elevated
liver enzymes. Abdominal ultrasonography and computed tomo-
graphic scan demonstrated a 5-cm right renal mass (renal cell
carcinoma). Results of the metastatic workup were negative, and
the patient underwent a laparoscopic right radical nephrectomy.
The laparoscopic dissection of the renal tumor was difficult and
eventually complicated by severe bleeding, which could not be
controlled laparoscopically. The abdomen was opened, and by
manual tamponade of the undersurface of the liver and infusion of
blood and intravenous fluids, blood pressure could be maintained.
The cardiothoracic surgical team was consulted. A standard
median sternotomy was performed and extended to the laparot-
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